✦ LIBER ✦

The preliminary results of the comparative efficacy of treatment with interferon alfa 2A and 2B in children with chronic hepatitis B

✍ Scribed by I. Mozer-Lisewska; A. Kowala-Piaskowska; M. Figlerowicz; W. Służewski

Book ID: 118568743
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 147 KB
Volume: 28
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(98)80976-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of chronic hepatitis B with in

Treatment of chronic hepatitis B with interferon alfa-2b

✍ Müller, R.; Baumgarten, R.; Markus, R.; Schulz, M.; Wittenberg, H.; Hintsche-Kil 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 383 KB

Treatment with interferon alfa-2b of chr

Treatment with interferon alfa-2b of chronic HDV hepatitis in children

✍ Di Marco, V; Volpes, R; Craxi, A; Marra, S; Rizzetto, M; Rosina, F; Barbera, C; 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Treatment of chronic NANB viral hepatiti

Treatment of chronic NANB viral hepatitis with recombinant interferon alfa-2b. Preliminary clinical and immunologic results

✍ Garda-Buey, L; Garcia-Monzon, C; Garcia-Sanchez, A; Pajares, JM; Moreno-Otero, R 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Treatment of chronic hepatitis C with re

Treatment of chronic hepatitis C with recombinant alfa interferon 2B

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Treatment of chronic posttransfusion non

Treatment of chronic posttransfusion non-A, non-B hepatitis with interferon alfa-2b

✍ Schvarcz, R; Weiland, O; Weijstål, R; Norkrans, G; Fryden, A; Foberg, U 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Interferon alfa-2b in combination with r

Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: Efficacy, safety, and pharmacokinetics

✍ Regino P. González-Peralta; Deirdre A. Kelly; Barbara Haber; Jean Molleston; Kar 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 3 views

Chronic hepatitis C virus (HCV) infection is usually asymptomatic in children, but significant liver disease may occur. We evaluated the efficacy, safety, and pharmacokinetics of interferon alfa-2b and ribavirin in children with chronic HCV. We determined the optimal ribavirin dose in an initial coh